Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy

Invention Grant

US12110334B2 Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy 有权

Patent Title: Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy
Application No.: US18153277

Application Date: 2023-01-11
Publication No.: US12110334B2

Publication Date: 2024-10-08
Inventor: Stephen L. Nishimura , Jianlong Lou , James D. Marks , Jody L. Baron , Yifan Cheng , Shenping Wu , Anthony Cormier , Naoki Takasaka
Applicant: The Regents of the University of California
Applicant Address: US CA Oakland
Assignee: The Regents of the University of California
Current Assignee: The Regents of the University of California
Current Assignee Address: US CA Oakland
Agency: Kilpatrick Townsend & Stockton LLP
The original application number of the division: US17155784 2021.01.22
Main IPC: G01N33/53
IPC: G01N33/53 ; A61P1/04 ; A61P31/20 ; A61P35/04 ; A61P37/04 ; C07K14/705 ; C07K16/00 ; C07K16/22 ; C07K16/28 ; C07K16/46 ; G01N33/563 ; A61K39/00

Abstract:

New antibodies and methods of use are described.

Public/Granted literature

Information query

Espacenet

IPC分类:

G	物理
G01	测量；测试
G01N	借助于测定材料的化学或物理性质来测试或分析材料（除免疫测定法以外包括酶或微生物的测量或试验入C12M，C12Q）
G01N33/00	利用不包括在G01N1/00至G01N31/00组中的特殊方法来研究或分析材料
G01N33/48	.生物物质，例如血、尿（G01N33/02，G01N33/26，G01N33/44，G01N33/46优先）；血球计数器（靠对一表面扫描来统计该表面上的血球数入G06M11/02）
G01N33/50	..••生物物质（例如血、尿）的化学分析；包括了生物特有的配体结合方法的测试；免疫学试验（除了免疫学试验以外包括酶或微生物，以及相应的组分或试纸的检测或试验，形成这些组分的工艺过程，在微生物的或酶的反应过程中反应条件的控制入C12Q）
G01N33/53	...免疫测定法；生物特异性结合测定；相应的生物物质